Skip to main content
Top
Published in: Supportive Care in Cancer 4/2007

01-04-2007 | Supportive Care International

A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA

Authors: Joel B. Epstein, Ira R. Parker, Matthew S. Epstein, Anurag Gupta, Susan Kutis, Daniela M. Witkowski

Published in: Supportive Care in Cancer | Issue 4/2007

Login to get access

Abstract

Background

The oral complications and morbidity resulting from overall cancer therapy utilizing radiation, chemotherapy, and/or stem cell transplantation can have significant impact on a patient’s health, quality of life, cost of care, and cancer management. There has been minimal health services research focusing on the status of medically necessary, oral supportive services at US cancer centers.

Methods

A pre-tested, survey questionnaire was distributed to the directors of National Cancer Institute (NCI)-designated comprehensive cancer centers to assess each institution’s resource availability and clinical practices, as it relates to the prevention and management of oral complications during cancer treatment.

Results

Sixteen of the 39 comprehensive cancer centers responded to the survey. Of the respondents, 56% of the centers did not have a dental department. The sites of delivery of oral supportive care services range from the provision of in-house dental care to community-based, private practice sites. No standard protocols were in place for either oral preventive care or for supportive services for oral complications during or after cancer therapy. Fifty percent of the responding comprehensive cancer centers reported orally focused research and/or clinical trial activities.

Conclusions

Comprehensive cancer care must include an oral care component, particularly for those cancer patients who are at high risk for oral complications. This requires a functional team of oral care providers collaborating closely within the oncology team. Considering the number of cancer patients receiving aggressive oncologic treatment that may result in oral toxicity, the impact of oral conditions on a compromised host, and the potential lack of appropriate resources and healthcare personnel to manage these complications, future research efforts are needed to identify the strengths and weaknesses of present oral supportive care delivery systems at both NCI-designated cancer centers and community-based oncology practices.
Literature
1.
go back to reference Epstein JB, Parker IR, Epstein MS, Stevenson-Moore P (2004) Cancer-related oral health care services and resources: a survey of oral and dental care in Canadian cancer centers. J Can Dent Assoc 70(5):302–304PubMed Epstein JB, Parker IR, Epstein MS, Stevenson-Moore P (2004) Cancer-related oral health care services and resources: a survey of oral and dental care in Canadian cancer centers. J Can Dent Assoc 70(5):302–304PubMed
2.
go back to reference Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98(7):1531–1539PubMedCrossRef Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98(7):1531–1539PubMedCrossRef
3.
go back to reference Rose-Ped A, Belim LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002) Complications of radiation therapy for head and neck cancers. Cancer Nurs 25:462–467 Rose-Ped A, Belim LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002) Complications of radiation therapy for head and neck cancers. Cancer Nurs 25:462–467
4.
go back to reference Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002) Complications of radiation therapy for head and neck cancers. The patient’s perspective. Cancer Nurs 25(6):461–469PubMedCrossRef Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuchs HJ (2002) Complications of radiation therapy for head and neck cancers. The patient’s perspective. Cancer Nurs 25(6):461–469PubMedCrossRef
5.
go back to reference Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046PubMedCrossRef Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST (2004) Mucositis study section of the multinational association for supportive care in cancer; International Society for Oral Oncology. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026–2046PubMedCrossRef
6.
go back to reference Sonis ST, Oster G, Fuchs H, Belim L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201–2205PubMed Sonis ST, Oster G, Fuchs H, Belim L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Miller C, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201–2205PubMed
7.
go back to reference Modi BJ, Knab B, Feldman LE et al (2005) Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother 6(7):1143–1155PubMedCrossRef Modi BJ, Knab B, Feldman LE et al (2005) Review of current treatment practices for carcinoma of the head and neck. Expert Opin Pharmacother 6(7):1143–1155PubMedCrossRef
8.
go back to reference Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE (2005) Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer 13:32–41PubMedCrossRef Barker GJ, Epstein JB, Williams KB, Gorsky M, Raber-Durlacher JE (2005) Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer 13:32–41PubMedCrossRef
9.
go back to reference Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952PubMedCrossRef Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH et al (2004) Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350(19):1945–1952PubMedCrossRef
10.
go back to reference Brizel DM, Albers MM, Fisher SR, Scher RL, Richtsmeier WJ, Hars V et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338(25):1798–1804PubMedCrossRef Brizel DM, Albers MM, Fisher SR, Scher RL, Richtsmeier WJ, Hars V et al (1998) Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338(25):1798–1804PubMedCrossRef
11.
go back to reference Bourhis J, Calais G, Lapeyre M, Tortochaux J, Alfonsi M, Sire C et al (2004) Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Semin Oncol 31(6):822–826PubMedCrossRef Bourhis J, Calais G, Lapeyre M, Tortochaux J, Alfonsi M, Sire C et al (2004) Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC). Semin Oncol 31(6):822–826PubMedCrossRef
12.
go back to reference Cooper JS, Pajak, TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944PubMedCrossRef Cooper JS, Pajak, TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB et al (2004) Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous cell carcinoma of the head and neck. N Engl J Med 350(19):1937–1944PubMedCrossRef
13.
go back to reference Duncan GG, Epstein JB, Tu D, Sayed SE, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 27(5):421–428PubMedCrossRef Duncan GG, Epstein JB, Tu D, Sayed SE, Bezjak A, Ottaway J, Pater J (2005) Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck 27(5):421–428PubMedCrossRef
14.
go back to reference Mignogna MD, Fedele S, Lo Russo L (2004) The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev (2):139–142CrossRef Mignogna MD, Fedele S, Lo Russo L (2004) The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev (2):139–142CrossRef
15.
go back to reference Institute of Medicine Report (1995) Dental education at the crossroads. National Academy Press, Washington, District of Columbia (2000) Institute of Medicine Report (1995) Dental education at the crossroads. National Academy Press, Washington, District of Columbia (2000)
16.
go back to reference Oral complications of cancer therapies: diagnosis, prevention and treatment (1990). NCI Monogr 9:3–8 Oral complications of cancer therapies: diagnosis, prevention and treatment (1990). NCI Monogr 9:3–8
17.
go back to reference US Department of Health and Human Services (2000) Oral health in America: a report of the Surgeon General. Rockville, Maryland: US Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, 2–3 US Department of Health and Human Services (2000) Oral health in America: a report of the Surgeon General. Rockville, Maryland: US Department of Health and Human Services, National Institute of Dental and Craniofacial Research, National Institutes of Health, 2–3
18.
go back to reference Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P (1987) Osteoradionecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 10:48–54PubMedCrossRef Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore P (1987) Osteoradionecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 10:48–54PubMedCrossRef
19.
go back to reference McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484–490PubMedCrossRef McCarthy GM, Awde JD, Ghandi H, Vincent M, Kocha WI (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484–490PubMedCrossRef
20.
go back to reference McCarthy GM, Sillings JR (1992) Orofacial complications of chemotherapy for breast cancer. Oral Surg Oral Med Oral Pathol 74:172–178PubMedCrossRef McCarthy GM, Sillings JR (1992) Orofacial complications of chemotherapy for breast cancer. Oral Surg Oral Med Oral Pathol 74:172–178PubMedCrossRef
Metadata
Title
A survey of National Cancer Institute-designated comprehensive cancer centers’ oral health supportive care practices and resources in the USA
Authors
Joel B. Epstein
Ira R. Parker
Matthew S. Epstein
Anurag Gupta
Susan Kutis
Daniela M. Witkowski
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 4/2007
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-006-0160-4

Other articles of this Issue 4/2007

Supportive Care in Cancer 4/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine